|
|
 |
 |
|
Joshua LaBaer
M.D., Ph.D.
Harvard Medical School/ Harvard Institute of Proteomics
Biography
Joshua LaBaer, M.D., Ph.D., is the Director of the Institute of Proteomics at Harvard Medical School. He attended the University of California at Berkeley as an undergraduate where he was awarded the University Medal for the Most Distinguished Graduating Senior. His studies continued at the University of California, San Francisco where he attended medical and graduate school and where he studied steroid regulation of DNA transcription and protein-DNA interactions with Dr. Keith Yamamoto. Dr LaBaer completed his clinical training at the Brigham and Women’s Hospital in Boston, where he specialized in internal medicine and the Dana-Farber Cancer Institute in Boston, where he studied medical oncology. He also pursued research interests at the Massachusetts General Hospital in Boston in the areas of breast cancer, mammalian cell cycle regulation and cell cycle checkpoint genes. He is currently an Attending Physician at the Dana-Farber Cancer Institute and holds an academic appointment through the Department of Biological Chemistry and Molecular Pharmacology at Harvard Medical School. Together with Dr. Ed Harlow, Dr. LaBaer founded the Harvard Institute of Proteomics in the spring of 1999.
e-mail: 
|
|
